1. BIZET D, ROUBAUDI F. La passiflore, Passiflora incarnata L., Passifloracées. Phytotherapy. 1988 ; 26 : 22-24.
2. LUTOMSKI J et al. The importance of the passionflower in medicine. Pharm Unserer Zeit. 1981 ; 10 (2) : 45-9.
3. LUTOMSKI J, WROCINSKI T. Pharmacodynamic properties of Passiflora incarnata preparations. The effect of alkaloid and flavonoid components on pharmacodynamic properties of the raw material. Biul. Inst. Roslin. Leczniczych. 1960: 6, 176-184.
4. BRUNETON J. Pharmacognosie (Phytochimie, plantes médicinales). 3ème édition 1999. Ed. Tec et doc.
5. RAYNAUD J. Prescription et conseil en phytothérapie. Ed Tec et Doc, 2005.
6. LESSIN AW et al. The central stimulant properties of some substituted indolealkylamines and ©-carbolines and their activities as inhibitors of monoamine oxidase and the uptake of
5-hydroxytryptamine. Br J Pharmacol Chemother. 1967 ; 29 (1) : 70-79.
7. DELLA LOGGIA R et al. Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them. Riv Neurol. 1981 ; 51 (5) : 297-310.